Total Payments
$13,612
2024 Payments
$1,510
Companies
64
Transactions
861
Medicare Patients
8,607
Medicare Billing
$597,123
Payment Breakdown by Category
Food & Beverage$13,562 (99.6%)
Education$49.83 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,562 | 854 | 99.6% |
| Education | $49.83 | 7 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,087 | 60 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,071 | 84 | $0 (2024) |
| Novo Nordisk Inc | $1,032 | 66 | $0 (2024) |
| PFIZER INC. | $1,004 | 75 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $996.71 | 54 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $986.47 | 35 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $812.54 | 46 | $0 (2024) |
| Merck Sharp & Dohme LLC | $812.11 | 62 | $0 (2024) |
| Lilly USA, LLC | $725.53 | 51 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $551.79 | 33 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,510 | 88 | PFIZER INC. ($239.01) |
| 2023 | $1,141 | 67 | Sumitomo Pharma America, Inc. ($213.42) |
| 2022 | $2,008 | 103 | Janssen Pharmaceuticals, Inc ($267.16) |
| 2021 | $1,899 | 131 | Novo Nordisk Inc ($301.36) |
| 2020 | $1,641 | 112 | AstraZeneca Pharmaceuticals LP ($305.98) |
| 2019 | $2,124 | 136 | Novo Nordisk Inc ($279.21) |
| 2018 | $1,554 | 105 | AstraZeneca Pharmaceuticals LP ($200.31) |
| 2017 | $1,736 | 119 | GlaxoSmithKline, LLC. ($316.22) |
All Payment Transactions
861 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: VACCINE | ||||||
| 12/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: UROLOGY | ||||||
| 12/04/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Gastroenterology | ||||||
| 11/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: PAIN | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Cardio-renal | ||||||
| 10/16/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: VACCINE | ||||||
| 10/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: PAIN | ||||||
| 10/01/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Endocrinology | ||||||
| 09/30/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: UROLOGY | ||||||
| 09/23/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Cardio-renal | ||||||
| 09/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $1.15 | General |
| Category: Cardio-renal | ||||||
| 09/11/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $9.18 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,875 | 3,144 | $273,133 | $141,538 |
| 2022 | 23 | 2,122 | 3,484 | $286,472 | $147,656 |
| 2021 | 27 | 2,319 | 3,989 | $306,413 | $163,324 |
| 2020 | 29 | 2,291 | 3,653 | $309,102 | $144,604 |
Total Patients
8,607
Total Services
14,270
Medicare Billing
$597,123
Procedure Codes
102
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 306 | 690 | $97,980 | $48,721 | 49.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 232 | 456 | $41,496 | $24,965 | 60.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 182 | 182 | $33,588 | $21,418 | 63.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 39 | 46 | $11,500 | $8,617 | 74.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 57 | 76 | $15,276 | $7,152 | 46.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 691 | 1,193 | $23,860 | $6,872 | 28.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 87 | $8,613 | $5,145 | 59.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 32 | 32 | $6,560 | $4,714 | 71.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 41 | 55 | $6,930 | $3,248 | 46.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 36 | 46 | $6,486 | $2,972 | 45.8% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 45 | 61 | $5,795 | $1,755 | 30.3% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 16 | 17 | $2,635 | $1,683 | 63.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $2,860 | $1,676 | 58.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $3,094 | $1,101 | 35.6% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 11 | 11 | $1,100 | $604.56 | 55.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 39 | 50 | $2,000 | $378.51 | 18.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 12 | 13 | $580.00 | $214.11 | 36.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 17 | $1,020 | $159.91 | 15.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 27 | 41 | $820.00 | $139.81 | 17.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 36 | 47 | $940.00 | $3.87 | 0.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 312 | 621 | $88,182 | $46,158 | 52.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 304 | 669 | $60,879 | $35,461 | 58.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 166 | 166 | $30,710 | $20,271 | 66.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 54 | 127 | $12,573 | $6,836 | 54.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 712 | 1,204 | $24,080 | $6,806 | 28.3% |
About Dr. Stephen Besson, MD
Dr. Stephen Besson, MD is a Adolescent Medicine healthcare provider based in Cynthiana, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750344552.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Besson, MD has received a total of $13,612 in payments from pharmaceutical and medical device companies, with $1,510 received in 2024. These payments were reported across 861 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($13,562).
As a Medicare-enrolled provider, Besson has provided services to 8,607 Medicare beneficiaries, totaling 14,270 services with total Medicare billing of $597,123. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Ad
Practice Information
- Specialty Adolescent Medicine
- Location Cynthiana, KY
- Active Since 04/11/2006
- Last Updated 02/05/2026
- Taxonomy Code 207RA0000X
- Entity Type Individual
- NPI Number 1750344552
Products in Payments
- XARELTO (Drug) $1,050
- ENTRESTO (Drug) $743.34
- FARXIGA (Drug) $677.49
- Kerendia (Drug) $478.12
- TRELEGY ELLIPTA (Drug) $467.51
- GEMTESA (Drug) $443.03
- NURTEC ODT (Drug) $418.15
- Ozempic (Drug) $417.61
- VRAYLAR (Drug) $386.41
- TRULICITY (Drug) $384.89
- SOLIQUA 100/33 (Biological) $329.86
- BELSOMRA (Drug) $321.16
- XIFAXAN (Drug) $300.97
- JARDIANCE (Drug) $285.20
- SOLIQUA (Drug) $273.67
- BREO (Drug) $257.90
- JANUVIA (Drug) $254.65
- ANORO (Drug) $248.21
- ELIQUIS (Drug) $247.54
- Yupelri (Drug) $225.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.